Results for tag: "Rotateq"

Rotateq is a vaccine used to protect against rotavirus, a virus that causes severe diarrhea in infants and young children. It is a live, oral vaccine that is given in three doses, typically at two, four, and six months of age. The vaccine is recommended for all infants in the United States and is included in the routine childhood immunization schedule. Rotateq is a relatively new vaccine, having been approved by the US Food and Drug Administration in 2006. It is the only rotavirus vaccine available in the US and is widely used in other countries as well. The vaccine has been shown to be highly effective in preventing rotavirus infection and has been credited with reducing the incidence of rotavirus-related hospitalizations and deaths in the US. The Rotateq market is composed of pharmaceutical companies that produce and distribute the vaccine. Major players in the market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, and Pfizer. Other companies, such as CSL Limited and Serum Institute of India, also produce and distribute the vaccine. Show Less Read more